Las Vegas, NV -- (SBWIRE) -- 12/13/2013 -- EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more .EquityObserver.com issues a special report on the following stocks: American Apparel Inc. (NYSEMKT:APP), Cell Therapeutics Inc (NASDAQ:CTIC), Enphase Energy Inc (NASDAQ:ENPH), Coronado Biosciences Inc (NASDAQ:CNDO)
American Apparel Inc. (NYSEMKT:APP) managed to keep its fall at -5.22% on above-normal volume of 1.11M shares. The stock settled at $1.09 after floating in a range of $1.06 to $1.16. Its latest price has reached market capitalization of $120.39 million. Its 52-week range has been $0.90 to $2.40. American Apparel, Inc. engages in the design, manufacture, distribution, and sale of branded fashion basic apparel products, and clothing and accessories for women, men, children, and babies. It primarily offers T-shirts, denim, sweaters, jackets, and accessories.
Has APP Found The Bottom and Ready To Move Up? Find Out Here
Cell Therapeutics Inc (NASDAQ:CTIC) traded up on a volume of 1.09 million, lower than its standard daily volume. Shares have gained 2.87% to $1.79. Over the last twelve months, the stock has gained 32.59% and faced a worst price of $0.97. Cell Therapeutics, Inc. acquires, develops, and commercializes treatments for cancer. The company primary focuses on the commercialization of PIXUVRI, an aza-anthracenedione derivative, which is in Phase III clinical trials for the treatment of multiply relapsed or refractory aggressive non-Hodgkin lymphoma. It is also developing Opaxio, a chemotherapeutic agent that is in Phase III clinical trials for the treatment of ovarian cancer; in Phase II clinical trials for the treatment of malignant brain cancer; and in Phase I-II clinical trials for the treatment of head and neck cancer.
For How Long CTIC’s Gloss will Attract Investors? Find out via this report
Enphase Energy Inc (NASDAQ:ENPH) settled -5.42% lower at $4.89 on above-normal volume of 1.07M shares during the last trading day. The stock has its 12-month high at $10 and 52-week low price was $2.89. It traded in a range of $4.54 to $5.13 during the last trading day. Enphase Energy, Inc., together with its subsidiaries, engages in the design, development, and sale of microinverter systems for the solar photovoltaic industry. Its microinverter system consists of microinverter and related accessories that convert direct current power to grid-compliant alternating current power; an Envoy communications gateway device that collects and transmits performance information from each solar module to the company?s hosted data center; and Enlighten Web-based software platform that collects and processes this information to enable customers to monitor and manage their solar power systems.
Will ENPH Get Buyers Even After The Recent Rally? Find Out Here
In the last trading session, Coronado Biosciences Inc (NASDAQ:CNDO) was down on high volume, trading at a volume of 1.76M versus its average daily volume of 1.43 million shares. At $1.78, the stock has attained market capitalization of 60.42 million. Coronado Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on the development of immunotherapy biologic agents for the treatment of autoimmune diseases and cancer. Its principal pharmaceutical product candidates in clinical development include TSO or CNDO-201, which is a biologic comprising Trichuris suis ovathe, the microscopic eggs of the porcine whipworm.
Why Should Investors Buy CNDO After the Recent Fall? Just Go Here and Find Out
About Equity Observer
Equity Observer delivers intra-day insights into the equities, tech and investment world. The website is a window into what’s going on in the business world and why.
EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
http://www.equityobserver.com/ has a no tolerance spam policy; we will not sell or re-distribute your email to any 3rd party. A If applicable, please also unsubscribe from the newsletter using the link at the bottom of the email if you no longer wish to receive our emails. We only send our newsletters to opt-in members.
PLEASE NOTE WELL: The http://www.equityobserver.com/" rel="nofollow" href="http://www.equityobserver.com/"> http://www.equityobserver.com/>
Employees and contributors are NOT registered as an Investment Adviser in any jurisdiction whatsoever.
Read Full Disclaimerat: http://www.equityobserver.com/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)